LEADER 02356nas  2200673-a 450 
001 996335908703316
005 20240413024551.0
011   $a1744-8379
035   $a(DE-599)ZDB2090846-5
035   $a(CKB)111056648275076
035   $a(CONSER)--2002243429
035   $a(EXLCZ)99111056648275076
100   $a20011114a20019999  ---         -
101 0 $aeng
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aExpert review of pharmacoeconomics & outcomes research
210   $aLondon $cFuture Drugs Ltd.$d[2001]-
210 21$aLondon :$cInforma Healthcare
210 31$aAbingdon, Oxford :$cTaylor & Francis
215   $a1 online resource
300   $aRefereed/Peer-reviewed
300   $aTitle from cover.
311   $aPrint version: Expert review of pharmacoeconomics & outcomes research. (DLC)  2002243429 (OCoLC)50638419 1473-7167 
531   $aEXPERT REVIEW OF PHARMACOECONOMICS AND OUTCOMES RESEARCH
531   $aEXPERT REV PHARMACOECON OUTCOMES RES
531   $aEXPERT REV. PHARMACOECON. OUTCOMES RES
531   $aEXPERT REV PHARM OUT
531 0 $aExpert rev. pharmacoecon. outcomes res.
606   $aDrugs$xCosts$vPeriodicals
606   $aChemotherapy$xEconomic aspects
606   $aPharmacology$xEconomic aspects$vPeriodicals
606   $aEconomics, Pharmaceutical
606   $aCost-Benefit Analysis
606   $aDecision Making
606   $aDrug Therapy$xeconomics
606   $aOutcome Assessment, Health Care
606   $aChemotherapy$xEconomic aspects$2fast$3(OCoLC)fst00853599
606   $aDrugs$xCosts$2fast$3(OCoLC)fst00898787
608   $aPeriodical.
608   $aReview.
608   $aPeriodicals.$2fast
608   $aPeriodicals.$2lcgft
615  0$aDrugs$xCosts
615  0$aChemotherapy$xEconomic aspects.
615  0$aPharmacology$xEconomic aspects
615 12$aEconomics, Pharmaceutical.
615 22$aCost-Benefit Analysis.
615 22$aDecision Making.
615 22$aDrug Therapy$xeconomics.
615 22$aOutcome Assessment, Health Care.
615  7$aChemotherapy$xEconomic aspects.
615  7$aDrugs$xCosts.
906   $aJOURNAL
912   $a996335908703316
920   $aexl_impl conversion
996   $aExpert review of pharmacoeconomics & outcomes research$92381170
997   $aUNISA